Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China

Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China

Submitted by admin on June 13, 2019 - 9:55pm
Source: 
BioSpace
News Tags: 
Tessa Therapeutics
cell therapy
cancer
China-Singapore Guangzhou Knowledge City
China
Headline: 
Tessa Therapeutics Forges $120 Million Joint Venture to Develop Cell Therapies in China
snippet: 

Singapore-based Tessa Therapeutics announced a joint venture with China-Singapore Guangzhou Knowledge City (CSGKC) to leverage Tessa’s cell therapies for development of cancer therapies in China.

Do Not Allow Advertisers to Use My Personal information